Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.

MLA

Dickinson, Laura, et al. “Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 73, no. 5, Sept. 2021, pp. e1200–07. EBSCOhost, https://doi.org/10.1093/cid/ciaa1861.

APA

Dickinson, L., Walimbwa, S., Singh, Y., Kaboggoza, J., Kintu, K., Sihlangu, M., Coombs, J.-A., Malaba, T. R., Byamugisha, J., Pertinez, H., Amara, A., Gini, J., Else, L., Heiberg, C., Hodel, E. M., Reynolds, H., Myer, L., Waitt, C., Khoo, S., … Orrell, C. (2021). Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 73(5), e1200–e1207. https://doi.org/10.1093/cid/ciaa1861

Chicago

Dickinson, Laura, Stephen Walimbwa, Yashna Singh, Julian Kaboggoza, Kenneth Kintu, Mary Sihlangu, Julie-Anne Coombs, et al. 2021. “Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 73 (5): e1200–1207. doi:10.1093/cid/ciaa1861.